Is Chemiesynth (Vapi) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Chemiesynth (Vapi) Ltd is a below average quality company .

Is Chemiesynth (Vapi) undervalued or overvalued?

The key valuation ratios of Chemiesynth (Vapi) Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Chemiesynth (Vapi) share price return in the past 10 years?

Data is not available for this company

Is Chemiesynth (Vapi) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Chemiesynth (Vapi) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

Chemiesynth (Vapi) Ltd - Stock Valuation and Financial Performance

Name: Chemiesynth (Vapi)
Brand: Chemiesynth (Vapi)

BSE: 539230 | NSE: | Chemicals | Small Cap

Place order

Chemiesynth (Vapi) Share Price

₹34.14 0.00 0.00%
as on 13-May'24 15:31

DeciZen - make an informed investing decision on Chemiesynth (Vapi)

Based on:

Data

M-Cap below 100cr DeciZen not available

Chemiesynth (Vapi) stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

10.5 Cr.

52-wk low:

52-wk high:

34.1

Is Chemiesynth (Vapi) Ltd an attractive stock to invest in?

10 Year X-Ray of Chemiesynth (Vapi): Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	2.6%	-7.8%	-3.9%	-2.2%	2.2%	11.1%	11%	22.9%	8.5%	4%	-
Value Creation Index ⓘ	-0.8	-1.6	-1.3	-1.2	-0.8	-0.2	-0.2	0.6	-0.4	-0.7	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	9.6	11.1	5.1	3.1	13.3	11.2	14.6	19.9	30.2	20.9	16
Sales YoY Gr.	-	15.6%	-54%	-39.7%	331.1%	-15.9%	30%	36.7%	51.7%	-30.6%	-
Adj EPS ⓘ	0.1	-3.2	-1.8	-1.2	0.3	3.7	4	11.6	4.7	1.8	-1.3
YoY Gr.	-	-2741.7%	NA	NA	NA	1100%	8.1%	187.6%	-59.3%	-61.8%	-
BVPS (₹) ⓘ	11.8	8.6	6.8	6.6	7.9	11.7	16	27.6	36.4	38.2	36.9
Adj Net Profit ⓘ	0	-1	-0.6	-0.4	0.1	1.1	1.2	3.6	1.5	0.6	0
Cash Flow from Ops. ⓘ	-0.1	-0.2	-1.5	-0.1	0.6	2.6	1.3	6.5	2.9	0.3	-
Debt/CF from Ops. ⓘ	-68.1	-41.1	-5.4	-61.4	14.4	3	7.6	1.7	4	50.6	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	9%	9.5%	12.9%	-30.6%
Adj EPS ⓘ	35.1%	42.2%	-23.5%	-61.8%
BVPSⓘ	14%	37.2%	33.8%	5%
Share Price	-	-	-	70.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	1	-29.7	-21.8	-17	4.3	38	29.1	53.2	14.7	4.8	-3.4
Op. Profit Mgn % ⓘ	5.5	-3.8	-2.7	-2.6	4.9	17.3	15.7	28	14.8	12.3	9.3
Net Profit Mgn % ⓘ	0.4	-8.7	-10.7	-11.7	0.7	10.2	8.5	17.8	4.8	2.6	-2.4
Debt to Equity ⓘ	1.8	2.5	3.9	4	3.3	2.1	2	1.3	1	1.2	0.8
Working Cap Days ⓘ	76	74	131	202	54	95	94	91	74	111	66
Cash Conv. Cycle ⓘ	-12	-14	-13	5	2	-16	-18	-41	-10	25	-47

Recent Performance Summary

Latest Financials - Chemiesynth (Vapi) Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-1.3	-
TTM Sales (₹ Cr.)	16.4	-
BVPS (₹.) ⓘ	36.9	-
Reserves (₹ Cr.) ⓘ	8	-
P/BV ⓘ	0.92	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	21.00 / 34.14
All Time Low / High (₹)	15.00 / 34.14
Market Cap (₹ Cr.)	10.5
Equity (₹ Cr.)	3.1
Face Value (₹)	10
Industry PE ⓘ	51

Management X-Ray of Chemiesynth (Vapi):

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Chemiesynth (Vapi)

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Chemiesynth (Vapi)

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	9.63	11.13	5.12	3.09	13.32	11.20	14.56	19.90	30.18	20.94
Operating Expenses ⓘ	9.10	11.56	5.26	3.17	12.67	9.26	12.28	14.32	25.71	18.37
Manufacturing Costs	2.21	3.37	1.82	1.26	2.93	4.96	6.38	7.40	11.03	8.33
Material Costs	4.84	6.22	1.74	0.61	8.12	1.91	3.01	3.15	9.78	5.28
Employee Cost	1.12	1.18	1.06	0.74	0.76	1.50	1.68	2.44	3.10	3.15
Other Costs ⓘ	0.93	0.78	0.64	0.56	0.87	0.88	1.21	1.32	1.80	1.60
Operating Profit ⓘ	0.53	-0.42	-0.14	-0.08	0.65	1.94	2.29	5.58	4.47	2.57
Operating Profit Margin (%)	5.5%	-3.8%	-2.7%	-2.5%	4.8%	17.3%	15.7%	28.0%	14.8%	12.3%
Other Income ⓘ	0.13	0.02	0.03	0.27	0.46	0.06	0.12	0.02	0.02	0
Interest ⓘ	0.30	0.29	0.23	0.19	0.19	0.09	0.28	0.48	0.50	0.59
Depreciation ⓘ	0.25	0.28	0.20	0.18	0.52	0.46	0.55	0.78	1.05	1.17
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0.92	0
Profit Before Tax ⓘ	0.11	-0.97	-0.54	-0.18	0.39	1.46	1.58	4.34	3.86	0.81
Tax ⓘ	0	0	0	0	0	0.28	0.27	0.77	1.14	0.26
Profit After Tax	0.11	-0.97	-0.54	-0.18	0.39	1.17	1.31	3.56	2.72	0.56
PAT Margin (%)	1.2%	-8.7%	-10.6%	-5.9%	3.0%	10.5%	9.0%	17.9%	9.0%	2.7%
Adjusted EPS (₹)	0.4	-3.2	-1.8	-0.6	1.3	3.8	4.3	11.6	8.9	1.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	3.77	2.79	2.25	2.02	2.41	3.59	4.90	8.46	11.17	11.73
Share Capital ⓘ	3.07	3.07	3.07	3.07	3.07	3.07	3.07	3.07	3.07	3.07
Reserves ⓘ	0.70	-0.28	-0.82	-1.05	-0.66	0.52	1.83	5.39	8.10	8.66
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	6.17	6.41	8	8.02	8.01	7.68	9.73	10.86	10.99	13.03
Long Term Debt	5.05	5.56	6.96	6.95	6.95	6.95	6.95	9.02	7.53	8.41
Short Term Debt	1.11	0.85	1.04	1.07	1.06	0.74	2.78	1.84	3.47	4.62
Trade Payables	2.08	2.16	0.76	1.24	0.97	3.17	3.02	6.02	4.27	2.91
Others Liabilities ⓘ	1.22	0.86	0.70	0.35	0.51	0.69	0.16	1.54	3.18	3.33
Total Liabilities ⓘ	13.23	12.23	11.70	11.63	11.90	15.13	17.81	26.87	29.62	31.01
Fixed Assets
Gross Block	16.76	16.64	16.72	16.25	16.45	17.93	20.03	28.88	31.93	35.22
Accumulated Depreciation	6.35	6.55	6.74	6.54	6.82	7.23	7.72	8.50	9.55	10.71
Net Fixed Assetsⓘ	10.41	10.09	9.98	9.71	9.62	10.69	12.31	20.39	22.38	24.51
CWIP ⓘ	0	0	0	0	0	0.24	1.34	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	1.68	0.76	0.65	0.97	0.36	1.21	1.79	1.43	2.17	2.90
Trade Receivables	0.33	0.82	0.44	0.21	0.99	1.69	1.59	3.70	3.44	2.71
Cash Equivalents	0.33	0.10	0.08	0.12	0.13	0.52	0.31	0.41	1.01	0.02
Others Assetsⓘ	0.47	0.46	0.54	0.62	0.80	0.76	0.47	0.94	0.62	0.86
Total Assets ⓘ	13.23	12.23	11.70	11.63	11.90	15.13	17.81	26.87	29.62	31.01

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	-0.09	-0.16	-1.50	-0.13	0.56	2.56	1.28	6.49	2.90	0.27
PBT ⓘ	0.11	-0.97	-0.54	-0.18	0.39	1.46	1.58	4.34	3.86	0.81
Adjustment ⓘ	0.41	0.52	0.39	0.09	0.62	0.48	0.74	1.20	1.53	1.74
Changes in Working Capital ⓘ	-0.32	0.55	-1.14	-0.04	-0.46	0.96	-0.54	1.67	-0.94	-1.16
Tax Paid ⓘ	0	0	0	0	0	-0.26	-0.24	-0.30	-1.07	-0.55
Cash Flow From Investing Activity ⓘ	0.28	0.06	-0.08	0.32	-0.38	-1.71	-3.20	-7.51	-3.05	-3.29
Capex	0.27	0.04	-0.09	0.31	-0.39	-1.72	-3.21	-7.51	-3.05	-3.29
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0	0	0
Cash Flow From Financing Activityⓘ	-0.03	-0.13	1.57	-0.16	-0.16	-0.45	1.70	1.13	0.74	2.04
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.27	0.51	1.40	-0.01	0	0	0	2.07	-1.49	0.89
Interest Paid ⓘ	0	0	0	-0.18	-0.16	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-0.30	-0.63	0.17	0.03	-0.01	-0.45	1.70	-0.94	2.23	1.15
Net Cash Flow ⓘ	0.16	-0.23	-0.02	0.03	0.01	0.40	-0.22	0.11	0.59	-0.98

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	3.22	-31.04	-22.95	-8.8	17.79	39.1	30.81	53.35	27.67	4.85
ROCE (%)	4.37	-7.04	-3.22	0.11	5.67	14.21	14.32	28.37	20.7	5.85
Asset Turnover Ratio	0.75	0.87	0.43	0.27	1.13	0.83	0.88	0.89	1.07	0.69
PAT to CFO Conversion(x)	-0.82	N/A	N/A	N/A	1.44	2.19	0.98	1.82	1.07	0.48
Working Capital Days
Receivable Days	11	19	45	38	16	44	41	48	43	54
Inventory Days	47	40	50	96	18	26	38	30	22	44
Payable Days	131	124	306	595	50	395	375	524	192	248

Chemiesynth (Vapi) Ltd Stock News

Chemiesynth (Vapi) Ltd FAQs

What is the share price of Chemiesynth (Vapi)?

Company share prices are keep on changing according to the market conditions. The closing price of Chemiesynth (Vapi) on 13-May-2024 15:31 is ₹34.14.

What is the market cap of Chemiesynth (Vapi)?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 13-May-2024 15:31 the market cap of Chemiesynth (Vapi) stood at ₹10.48.

What is the P/E ratio of Chemiesynth (Vapi)?

The latest P/E ratio of Chemiesynth (Vapi) as of 13-May-2024 15:31 is 0.00.

What is the P/B ratio of Chemiesynth (Vapi)?

The latest P/B ratio of Chemiesynth (Vapi) as of 13-May-2024 15:31 is 0.92.

What is the 52-week high and low of Chemiesynth (Vapi)?

The 52-week high of Chemiesynth (Vapi) is ₹34.14 and the 52-week low is ₹21.00.

What is the TTM revenue of Chemiesynth (Vapi)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Chemiesynth (Vapi) is ₹16.43 ( Cr.) .

About Chemiesynth (Vapi) Ltd

Chemiesynth (Vapi) Limited was incorporated as a private limited company in the year 1984 under the Companies Act, 1956. The foundation of its business is built on strong relationships, innovation and uncompromising ethical standards. It’s constantly strive to create significant value for entrepreneurs and companies by helping them execute the right strategy.

Business area of the company

The company is into manufacturing of chemical dyes and specialty intermediates for leading agro chemical and pharmaceutical companies in India.

Products of the company